AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 276: G1521-G1530, 1999;
0193-1857/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurjak, M.
Right arrow Articles by Allescher, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurjak, M.
Right arrow Articles by Allescher, H. D.
Vol. 276, Issue 6, G1521-G1530, June 1999

NO releases bombesin-like immunoreactivity from enteric synaptosomes by cross-activation of protein kinase A

M. Kurjak, R. Fritsch, D. Saur, V. Schusdziarra, and H. D. Allescher

Department of Internal Medicine II, Technical University Munich, 81675 Munich, Germany

The effect of nitric oxide (NO) on the release of bombesin-like immunoreactivity (BLI) was examined in synaptosomes of rat small intestine. The NO donor S-nitroso-N-acetylpenicillamine (SNAP; 10-7 to 10-4 M) significantly stimulated BLI release. In the presence of the NO scavenger oxyhemoglobin (10-3 M) or the guanylate cyclase inhibitor ODQ (10-5 M), SNAP-induced BLI release was antagonized. In addition, SNAP increased the synaptosomal cGMP content and elevation of cGMP levels by zaprinast (3 × 10-5 M), an inhibitor of the cGMP-specific phosphodiesterase (PDE) type 5, and increased basal and SNAP-induced BLI release. NO-induced BLI release was blocked by Rp-adenosine 3',5'-cyclic monophosphorothioate (3 × 10-5 M and 10-4 M), an inhibitor of the cAMP-dependent protein kinase A, whereas KT-5823 (3 × 10-6 M) and Rp-8-(4-chlorophenylthio)-cGMP (5 × 10-5 M), inhibitors of the cGMP-dependent protein kinase G, had no effect. Because cGMP inhibits the cAMP-specific PDE3, thereby increasing cAMP levels, the role of PDE3 was investigated. Trequinsin (10-8 M), a specific blocker of PDE3, stimulated basal BLI release but had no additive effect on NO-induced release, suggesting a similar mechanism of action. These data demonstrate that because of a cross-activation of cAMP-dependent protein kinase A by endogenous cGMP BLI can be released by NO from enteric synaptosomes.

nerve terminals; enteric nervous system; gastrin-releasing peptide; phosphodiesterase 3; phosphodiesterase 5; nitric oxide


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Saur, W. L. Neuhuber, B. Gengenbach, A. Huber, V. Schusdziarra, and H.-D. Allescher
Site-specific gene expression of nNOS variants in distinct functional regions of rat gastrointestinal tract
Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G349 - G358.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online